Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial - Wikidata - awgldk - TriplyDB

Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial

Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial

http://www.wikidata.org/entity/Q33796958

about

Interventions for cutaneous Bowen's disease Nanomaterials for photo-based diagnostic and therapeutic applications Can nanotechnology potentiate photodynamic therapy?The elements of life and medicines Silicon phthalocyanine 4 phototoxicity in Trichophyton rubrum.Quantification of photocyanine in human serum by high-performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study Targeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancer Shining light on nanotechnology to help repair and regeneration.Cutaneous penetration of the topically applied photosensitizer Pc 4 as detected by intravital 2-photon laser scanning microscopy.Involvement of the mitochondria-caspase pathway in HeLa cell death induced by 2-ethanolamino-2-demethoxy-17-ethanolimino-hypocrellin B (EAHB)-mediated photodynamic therapy.Biodistribution Study of Nanoparticle Encapsulated Photodynamic Therapy Drugs Using Multispectral Imaging Synthesis, spectroscopic, and cellular properties of α-pegylated cis-A2B2- and A3B-types ZnPcs Preliminary clinical and pharmacologic investigation of photodynamic therapy with the silicon phthalocyanine photosensitizer pc 4 for primary or metastatic cutaneous cancers.Lysosomal signaling enhances mitochondria-mediated photodynamic therapy in A431 cancer cells: role of iron Fluence rate-dependent photobleaching of intratumorally administered Pc 4 does not predict tumor growth delay C6-pyridinium ceramide sensitizes SCC17B human head and neck squamous cell carcinoma cells to photodynamic therapy Syntheses and Photodynamic Activity of Pegylated Cationic Zn(II)-Phthalocyanines in HEp2 Cells.Mitoferrin-2-dependent mitochondrial iron uptake sensitizes human head and neck squamous carcinoma cells to photodynamic therapy Self-assembled IR780-loaded transferrin nanoparticles as an imaging, targeting and PDT/PTT agent for cancer therapy.Activated T cells exhibit increased uptake of silicon phthalocyanine Pc 4 and increased susceptibility to Pc 4-photodynamic therapy-mediated cell death Photodynamic therapy with Pc 4 induces apoptosis of Candida albicans.Recent developments in nanomedicine for melanoma treatment.On the in vivo photochemical rate parameters for PDT reactive oxygen species modeling.Evaluation of Silicon Phthalocyanine 4 Photodynamic Therapy Against Human Cervical Cancer Cells In Vitro and in Mice Potent peptide-conjugated silicon phthalocyanines for tumor photodynamic therapy.DNA Intercalating RuIIPolypyridyl Complexes as Effective Photosensitizers in Photodynamic Therapy

P2860

Q24201818-34622ECA-6C1D-4293-99CC-FA3841BFD961 Q27013549-B0C400F7-585E-4612-8B82-D8C054DBBC9A Q28388084-15C789F8-2BF0-4E16-9BBB-D3323BD5FF96 Q28649323-DF44A284-89DB-40AE-A335-59F85C8CFC25 Q33797831-0674E0DE-FFAD-462A-A7D2-E17803CF7B3E Q33891287-04E9E17E-5EE7-45C7-BD88-C5E067C1EAA6 Q34139484-33B59EC3-6B9C-4FCB-922F-9FFF4269DC0E Q34404413-042E1160-12F5-4A8E-91A5-D727C61C1DDF Q34409083-F0CCC549-4BD6-4A4B-BE56-6CE2D5447716 Q34420750-6E138589-2E6D-4B23-B758-B41B50CA3A7D Q35044061-F1CBCBB8-55D5-4A04-8850-E74895C6D6FD Q35694521-7ACB2683-83CC-4532-A22F-52832C88A3FC Q35971100-D5E235E2-4F30-4C1D-BA57-8C2302F8C61C Q35991511-BD93CC88-788F-465B-9043-8F76A9F9DA63 Q36201089-D2DCF988-9577-4690-80D1-A7601D87BE57 Q36326049-93F4D643-FDC1-4977-87E3-A3040A913E8C Q36329645-5042D161-9E8C-427B-B62D-CD0B157FB5A0 Q36508761-45F90B96-ACEF-44B7-A5B5-9FCDAA9FC143 Q36986485-FBA9E5B2-782E-4D1E-B9CF-4144230D4F7B Q37055477-DB020C52-573D-422D-9E62-F7231B54587E Q38550027-85F2C109-772D-4A6A-857A-CBBC01AE735D Q38740124-35474133-3D6B-4550-98EA-1B13D2C94730 Q38976558-1C30649E-F262-4DE6-8DFF-BEBC093DF321 Q41572183-A5D46C54-E27D-4EA0-85B7-9F8D7E83CE2F Q47712185-D76153ED-91A0-4A18-A3B4-8CA57C25F7DC Q59265333-F65E66DD-4ADB-4760-8FBA-8ECA93B88EE8

P2860

Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial

http://www.wikidata.org/entity/Q33796958

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Silicon phthalocyanine (Pc 4) ...... ts of a phase 1 clinical trial

@ast

Silicon phthalocyanine (Pc 4) ...... ts of a phase 1 clinical trial

@en

type

label

Silicon phthalocyanine (Pc 4) ...... ts of a phase 1 clinical trial

@ast

Silicon phthalocyanine (Pc 4) ...... ts of a phase 1 clinical trial

@en

prefLabel

Silicon phthalocyanine (Pc 4) ...... ts of a phase 1 clinical trial

@ast

Silicon phthalocyanine (Pc 4) ...... ts of a phase 1 clinical trial

@en

P1433

Q33796958-3BA2872A-1B02-4EB0-B215-1D075DDAB332

P1476

Q33796958-EFD47711-002F-45AD-9A9F-4409C76219A9

P2093

Q33796958-0CC6DD99-4968-46D4-99A4-985A5F858340

Q33796958-1197DFCF-5E4E-4D87-AD8C-C5C75E800A7B

Q33796958-2826B7E5-54B0-4C60-B40C-B102B4F4F50D

Q33796958-4BB210D4-F485-4C0A-8C95-CF467341521F

Q33796958-6E909C82-8E99-445D-8D83-C945D5C0AC05

Q33796958-777605BC-DE08-44BD-A1CC-F64133571016

Q33796958-8D0F89B2-72DD-40C5-8325-EC90A4E562F8

Q33796958-AC57369C-7869-4AD9-866D-02C0C3B3BCE7

Q33796958-E06F727D-2A77-4A1A-9FCF-FF16EFB100B1

Q33796958-F376149B-341A-4C8A-8533-E5E09A4AF15B

P2860

Q33796958-009F7E13-58F8-4C7F-86E6-58D31DDCB628

Q33796958-04ADF97F-FA3C-455B-A6B9-BEBA7629D870

Q33796958-085E2B0C-A7A8-413E-92A1-F744959A00A0

Q33796958-0A0FD811-64FE-47E0-8FE2-3EFC6AC22331

Q33796958-0CF17FDB-A4CB-446C-9EEB-32E27B097CA7

Q33796958-10B0059E-890D-45BD-A095-DAAA9B890B49

Q33796958-13F4BD88-77C5-4875-B1DC-C1827A36C020

Q33796958-2D2A0FB2-2030-4B88-A298-117603456762

Q33796958-2E776261-BD67-4443-BB51-07276D0F2D3E

Q33796958-36902B86-585B-41E7-BECB-704E6E962855

P304

Q33796958-34BC66E0-D6AB-40DB-AD91-43FD68BA724F

P31

Q33796958-7D5F9FB7-F66D-4958-BBA9-53082768B17E

P356

Q33796958-BA6E49A7-0B1C-45CE-9B9D-A777205CBC8C

P433

Q33796958-107D5E70-8E1A-40C3-8CAA-9183D9123231

P478

Q33796958-C03FF51B-4145-445A-8780-42C488D362B5

P577

Q33796958-20822FF0-AA13-4A3D-AE10-571322E31B89

P698

Q33796958-D37FF7A3-CC4E-45E8-ACC7-A0CD1BAE0AB4

P921

Q33796958-39BE1CCB-DEE7-4EC1-9325-8DD928BEB8CD

P932

Q33796958-224ACC4B-96F9-4FD2-BEC2-95911C7E1421

P356

P1433

Lasers in Surgery and Medicine

P1476

Silicon phthalocyanine (Pc 4) ...... ts of a phase 1 clinical trial

@en

P2093

Andrew H Hsia

http://www.w3.org/2001/XMLSchema#string

Christi L Malbasa

http://www.w3.org/2001/XMLSchema#string

Diana Santo-Domingo

http://www.w3.org/2001/XMLSchema#string

Elma D Baron

http://www.w3.org/2001/XMLSchema#string

Janine D Miller

http://www.w3.org/2001/XMLSchema#string

Kaija K Hanneman

http://www.w3.org/2001/XMLSchema#string

Kevin D Cooper

http://www.w3.org/2001/XMLSchema#string

Nancy L Oleinick

http://www.w3.org/2001/XMLSchema#string

Pingfu Fu

http://www.w3.org/2001/XMLSchema#string

Valdir C Colussi

http://www.w3.org/2001/XMLSchema#string

P2860

Interval Estimation for a Binomial Proportion

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.

Photodynamic therapy-induced death of MCF-7 human breast cancer cells: a role for caspase-3 in the late steps of apoptosis but not for the critical lethal event.

Induction of apoptotic cell death by photodynamic therapy in human keratinocytes.

WHO-EORTC classification for cutaneous lymphomas.

The role of apoptosis in response to photodynamic therapy: what, where, why, and how.

Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma.

Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005.

Molecular effectors of multiple cell death pathways initiated by photodynamic therapy.

P304

728-735

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/LSM.20984

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21246576

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial

P932

3149858

http://www.w3.org/2001/XMLSchema#string